Literature DB >> 10796433

Surgery for lumbar disc prolapse.

J N Gibson1, I C Grant, G Waddell.   

Abstract

OBJECTIVES: The primary rationale for surgery for disc prolapse is to relieve nerve root irritation or compression due to herniated disc material. Claims of the merits of alternative surgical procedures are made without clear evidence about clinical outcomes. The objective of this review was to assess the effects of surgical interventions for the treatment of lumbar disc prolapse. SEARCH STRATEGY: We searched the Cochrane Controlled Trials Register, Medline, Embase, Biosis, Dissertation Abstracts, Index to UK Thesis, and reference lists of the retrieved articles up to March 1997 and we corresponded with experts. SELECTION CRITERIA: Randomised and quasi-randomised trials of the surgical management of lumbar disc prolapse. DATA COLLECTION AND ANALYSIS: Two reviewers assessed trial quality and extracted data from published papers. Additional information was sought from the authors if necessary. MAIN
RESULTS: Twenty-seven trials were found. There were methodological weaknesses in many of the trials. Sixteen of the 27 trials were of some form of chemonucleolysis. Ten trials compared different surgical techniques, although only one of these compared surgical discectomy with conservative management. Surgical discectomy produced better clinical outcomes than chemonucleolysis with chymopapain, and chemonucleolysis produced better clinical outcomes than placebo. Three trials showed no difference in clinical outcomes between microdiscectomy and standard discectomy. Three trials failed to show a significant reduction in scar formation or improved clinical outcomes by inserting an inter-position membra ne to cover the spinal dura after discectomy. Three trials of percutaneous discectomy provided moderate evidence that it produces poorer clinical outcomes than standard discectomy or chymopapain. We found no published randomised trials of laser discectomy. REVIEWER'S
CONCLUSIONS: Chemonucleolysis is more effective than placebo and it is less invasive but less effective than surgical disectomy. Surgical discectomy for carefully selected patients with sciatica due to lumbar disc prolapse provides faster relief from the acute attack than conservative management, although any positive or negative effects on the lifetime natural history of the underlying disc disease are unclear.

Entities:  

Mesh:

Year:  2000        PMID: 10796433     DOI: 10.1002/14651858.CD001350

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  6 in total

1.  Effect sizes of non-surgical treatments of non-specific low-back pain.

Authors:  A Keller; J Hayden; C Bombardier; M van Tulder
Journal:  Eur Spine J       Date:  2007-07-10       Impact factor: 3.134

2.  Comparison of EQ-5D, HUI, and SF-36-derived societal health state values among spine patient outcomes research trial (SPORT) participants.

Authors:  Christine M McDonough; Margaret R Grove; Tor D Tosteson; Jon D Lurie; Alan S Hilibrand; Anna N A Tosteson
Journal:  Qual Life Res       Date:  2005-06       Impact factor: 4.147

Review 3.  Degeneration of the intervertebral disc.

Authors:  Jill P G Urban; Sally Roberts
Journal:  Arthritis Res Ther       Date:  2003-03-11       Impact factor: 5.156

4.  Prolonged conservative treatment or 'early' surgery in sciatica caused by a lumbar disc herniation: rationale and design of a randomized trial [ISRCT 26872154].

Authors:  Wilco C Peul; Hans C van Houwelingen; Wilbert B van der Hout; Ronald Brand; Just A H Eekhof; Joseph Th J Tans; Ralph T W M Thomeer; Bart W Koes
Journal:  BMC Musculoskelet Disord       Date:  2005-02-11       Impact factor: 2.362

5.  Surgically treated symptomatic prolapsed lumbar and sacral intervertebral discs in females: a comparative study of incidence and causative factors and treatment.

Authors:  M O N Ibe
Journal:  Niger J Surg       Date:  2012-07

6.  Distribution pattern of surgically treated symptomatic prolapsed lumbar and sacral intervertebral discs in males.

Authors:  Ibe Michael Onwuzuruike Nnamdi
Journal:  Niger Med J       Date:  2013-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.